The 340B program has outgrown patient demands and requires additional restrictions and oversight, according to a new report from a [...] …
Category: General
Specialty and community pharmacies play an essential role in the 340B program and must be protected against interference by drug [...] …
The head of Council for Citizens Against Government Waste (CCAGW)—the lobbying arm of a watchdog group which has long advocated [...] …
November will bring an epic battle for both the U.S. presidency and control in Congress, both of which could have [...] …
German drugmaker Bayer will no longer exempt federal grantees from its 340B contract pharmacy policy beginning Oct. 1—the same day [...] …
The 340B program’s growth in recent decades has helped it attract a growing number of corporate and private equity investments, [...] …
SPONSORED CONTENT
On June 18th, RxParadigm hosted a webinar to discuss the pressing need for a 340B clearinghouse. Legislative changes at both state and federal levels for the 340B program could be imminent, requiring all stakeholders to adapt to new standards
…
French drugmaker Sanofi has reportedly asked some hospitals for data relating to 340B purchases of a popular drug used to [...] …
More transparency surrounding 340B hospital operations is needed to ensure drug discount savings are being used to improve patient care, [...] …
A major hospital advocacy group recently urged congressional advisers to “carefully consider” the potential negative consequences of any new efforts [...] …